These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19889869)

  • 21. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss.
    Simoneau JA; Veerkamp JH; Turcotte LP; Kelley DE
    FASEB J; 1999 Nov; 13(14):2051-60. PubMed ID: 10544188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myostatin and adipokines: The role of the metabolically unhealthy obese phenotype in muscle function and aerobic capacity in young adults.
    Carvalho LP; Basso-Vanelli RP; Di Thommazo-Luporini L; Mendes RG; Oliveira-Junior MC; Vieira RP; Bonjorno-Junior JC; Oliveira CR; Luporini R; Borghi-Silva A
    Cytokine; 2018 Jul; 107():118-124. PubMed ID: 29246653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ghrelin, leptin, adiponectin, and insulin levels and concurrent and future weight change in overweight, postmenopausal women.
    Soni AC; Conroy MB; Mackey RH; Kuller LH
    Menopause; 2011 Mar; 18(3):296-301. PubMed ID: 21449093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity.
    Menshikova EV; Ritov VB; Toledo FG; Ferrell RE; Goodpaster BH; Kelley DE
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E818-25. PubMed ID: 15585590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight.
    Rosenbaum M; Goldsmith R; Bloomfield D; Magnano A; Weimer L; Heymsfield S; Gallagher D; Mayer L; Murphy E; Leibel RL
    J Clin Invest; 2005 Dec; 115(12):3579-86. PubMed ID: 16322796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes.
    Højlund K; Frystyk J; Levin K; Flyvbjerg A; Wojtaszewski JF; Beck-Nielsen H
    Diabetologia; 2006 Jun; 49(6):1283-91. PubMed ID: 16609880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of weight loss on insulin sensitivity, skeletal muscle composition and capillary density in obese non-diabetic subjects.
    Niskanen L; Uusitupa M; Sarlund H; Siitonen O; Paljärvi L; Laakso M
    Int J Obes Relat Metab Disord; 1996 Feb; 20(2):154-60. PubMed ID: 8646252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women.
    Simoneau JA; Colberg SR; Thaete FL; Kelley DE
    FASEB J; 1995 Feb; 9(2):273-8. PubMed ID: 7781930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calorie Restriction-induced Weight Loss and Exercise Have Differential Effects on Skeletal Muscle Mitochondria Despite Similar Effects on Insulin Sensitivity.
    Menshikova EV; Ritov VB; Dube JJ; Amati F; Stefanovic-Racic M; Toledo FGS; Coen PM; Goodpaster BH
    J Gerontol A Biol Sci Med Sci; 2017 Dec; 73(1):81-87. PubMed ID: 28158621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of altered body weight on energy expenditure.
    Kinney JM
    Nutr Rev; 1995 Sep; 53(9):265-8. PubMed ID: 8577410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight loss-induced rise in plasma pollutant is associated with reduced skeletal muscle oxidative capacity.
    Imbeault P; Tremblay A; Simoneau JA; Joanisse DR
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E574-9. PubMed ID: 11832359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of muscle uncoupling protein 2 content in human obesity associates with reduced skeletal muscle lipid utilization.
    Simoneau JA; Kelley DE; Neverova M; Warden CH
    FASEB J; 1998 Dec; 12(15):1739-45. PubMed ID: 9837864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower extremity muscle size and strength and aerobic capacity decrease with caloric restriction but not with exercise-induced weight loss.
    Weiss EP; Racette SB; Villareal DT; Fontana L; Steger-May K; Schechtman KB; Klein S; Ehsani AA; Holloszy JO;
    J Appl Physiol (1985); 2007 Feb; 102(2):634-40. PubMed ID: 17095635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated fasting insulin concentrations associate with impaired insulin signaling in skeletal muscle of healthy subjects independent of obesity.
    Korsheninnikova E; Seppälä-Lindroos A; Vehkavaara S; Goto T; Virkamäki A
    Diabetes Metab Res Rev; 2002; 18(3):209-16. PubMed ID: 12112939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutively active calcineurin in skeletal muscle increases endurance performance and mitochondrial respiratory capacity.
    Jiang LQ; Garcia-Roves PM; de Castro Barbosa T; Zierath JR
    Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E8-E16. PubMed ID: 19861587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of chronic weight perturbation on energy homeostasis and brain structure in mice.
    Ravussin Y; Gutman R; Diano S; Shanabrough M; Borok E; Sarman B; Lehmann A; LeDuc CA; Rosenbaum M; Horvath TL; Leibel RL
    Am J Physiol Regul Integr Comp Physiol; 2011 Jun; 300(6):R1352-62. PubMed ID: 21411766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Separate and combined effects of exercise training and weight loss on exercise efficiency and substrate oxidation.
    Amati F; Dubé JJ; Shay C; Goodpaster BH
    J Appl Physiol (1985); 2008 Sep; 105(3):825-31. PubMed ID: 18617627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle-specific loss of Bmal1 leads to disrupted tissue glucose metabolism and systemic glucose homeostasis.
    Harfmann BD; Schroder EA; Kachman MT; Hodge BA; Zhang X; Esser KA
    Skelet Muscle; 2016; 6():12. PubMed ID: 27486508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in glucose and lipid metabolism following weight loss produced by a very low calorie diet in obese subjects.
    Bryson JM; King SE; Burns CM; Baur LA; Swaraj S; Caterson ID
    Int J Obes Relat Metab Disord; 1996 Apr; 20(4):338-45. PubMed ID: 8680461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6.
    Bach D; Naon D; Pich S; Soriano FX; Vega N; Rieusset J; Laville M; Guillet C; Boirie Y; Wallberg-Henriksson H; Manco M; Calvani M; Castagneto M; Palacín M; Mingrone G; Zierath JR; Vidal H; Zorzano A
    Diabetes; 2005 Sep; 54(9):2685-93. PubMed ID: 16123358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.